Metrics to compare | 7882 | Peers Peers - average of corresponding metrics from companies closely matching 7882: 4157, 544825, PCJEWELLER, A263800, LABS | Sector Sector - Average of metrics from a broad group of related Financial sector companies | Relationship Relationship7882PeersSector |
|---|---|---|---|---|
P/E Ratio | 6.7x | 9.7x | 9.1x | |
PEG Ratio | 0.01 | 0.11 | 0.03 | |
Price/Book | 1.9x | 0.8x | 1.0x | |
Price / LTM Sales | 5.9x | 0.5x | 2.8x | |
Upside (Analyst Target) | - | 4.3% | 19.5% | |
Fair Value Upside | Unlock | 13.3% | 3.8% | Unlock |
Beiley Biofund Inc. is a venture capital firm specializing in early-stage and late-stage investments. The firm seeks to invest in unmet medical needs, including chronic diseases associated with aging and cancer. It invests in biotechnology trends driven by precision medicine, artificial intelligence, and emerging platform technologies. The firm seeks to invest in novel drugs, medical devices, healthcare services, and veterinary medicine. Beiley Biofund Inc. was founded in 2013 and is based in Taipei, Taiwan.